CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis

Thomas J, Wang R, Batra R, Boehner A, Garzorz-Stark N, Eberlein B, Theis F, Biedermann T, Schmidt-Weber C, Zink A, Eyerich K, Eyerich S (2021)

Publication Type: Journal article

Publication year: 2021

Journal

Journal of Investigative Dermatology Elsevier

Book Volume: 141

Pages Range: 681-685.e6

Journal Issue: 3

DOI: 10.1016/j.jid.2020.05.122

Involved external institutions

Technische Universität Dresden DE Germany (DE) Technische Universität München (TUM) DE Germany (DE) Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (HMGU) / Helmholtz Munich DE Germany (DE)

How to cite

APA:

Thomas, J., Wang, R., Batra, R., Boehner, A., Garzorz-Stark, N., Eberlein, B.,... Eyerich, S. (2021). CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis. Journal of Investigative Dermatology, 141(3), 681-685.e6. https://doi.org/10.1016/j.jid.2020.05.122

MLA:

Thomas, Jenny, et al. "CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis." Journal of Investigative Dermatology 141.3 (2021): 681-685.e6.

BibTeX: Download